LexisNexis® Legal Newsroom
Avandia Off Market In Europe; FDA To Restrict Its Use, Orders Probe of GSK Study

(Mealey's) The European Medicines Agency (EMA) on Sept. 23 recommended that the marketing authorization for GlaxoSmithKline PLC's (GSK) controversial anti-diabetes drug Avandia be suspended, and the Food and Drug Administration simultaneously said it will significantly restrict Avandia use in...

Glaxo Settles Bad Drug Claim For More Than $40 Million

PROVIDENCE, R.I. - (AP) The American subsidiary of a major British drug maker, GlaxoSmithKline LLC, has agreed to pay more than $40 million to 37 states and Washington, D.C., to settle complaints alleging manufacturing process issues at a now-shuttered plant in Puerto Rico, the company and several states'...

Lawsuits Follow Diabetes Drug Actos' Link To Cancer Risk

TRENTON, N.J. - (AP) The maker of the world's best-selling diabetes drug is facing hundreds of lawsuits and likely a big sales drop as suspicion grows that taking the pill for more than a year raises the risk of bladder cancer. In June, Takeda Pharmaceuticals Co. Ltd. halted sales of Actos. . . ...